| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
CAMBRIDGE, Mass.—The stretchiness that allows living tissues to expand, contract, stretch and bend throughout a lifetime is the result of a protein molecule called tropoelastin. Remarkably, this molecule can be stretched to eight times its length and always returns back to its original size.
 
Now, for the first time, researchers have decoded the molecular structure of this complex molecule, as well as the details of what can go wrong with its structure in various genetically driven diseases.
 
Tropoelastin is the precursor molecule of elastin, which along with structures called microfibrils is the key to flexibility of tissues including skin, lungs and blood vessels. But the molecule is complex, made up of 698 amino acids in sequence and filled with disordered regions, so unraveling its structure has been a major challenge for science.
 
That challenge reportedly has been solved by a team of researchers who used a combination of molecular modeling and experimental observation to build an atom-by-atom picture of the molecule’s structure. The results appeared recently in the Proceedings of the National Academy of Sciences.
 
“The structure of tropoelastin has been elusive,” said Dr. Anna Tarakanova, a postdoctoral researcher and one of the paper’s co-authors, noting that traditional characterization methods are insufficient for decoding this molecule “because it’s very large, disordered, and dynamic.” But the combination of computer modeling and experimental observations this team used “allowed us to predict a fully atomistic structure of the molecule."
 
The study showed how certain different disease-causing mutations in the single gene that controls the formation of tropoelastin change the molecule’s stiffness and dynamic responses, which could ultimately help in the design of treatments or countermeasures for these conditions. Other “artificial” mutations induced by the researchers, that do not correspond to any known naturally occurring mutations, can be used to better understand the function of the specific part of the gene affected by that mutation.
 
“We’re interested in probing a particular region of the molecule to understand the function of that region,” Tarakanova said. “In addition to imparting elasticity, the molecule plays a key role in cell signaling and cell adhesion, affecting cellular processes which are driven by interactions with specific sequences within the molecule.”
 
“Understanding the structure of this molecule is not only important in the context of disease,” added Dr. Markus Buehler, the Jerry McAfee Professor in Engineering and head of the MIT Department of Civil and Environmental Engineering, who also was one of the paper’s authors, “but can also enable us to translate the knowledge from this biomaterial to synthetic polymers, which can be designed to meet certain engineering needs. Engineering the balance of order and disorder in the context of desired properties could open doors to new designer materials.” .
-------------------------------------------------------
Edited from an article by David L. Chandler of the MIT News Office

Related Topics

Published In

Volume 14 - Issue 9 | September 2018

September 2018

September 2018 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue